Josephine M Forbes
Josephine M Forbes
Mater Research Institute - The University of Queensland
Verified email at mater.uq.edu.au - Homepage
Title
Cited by
Cited by
Year
Mechanisms of diabetic complications
JM Forbes, ME Cooper
Physiological reviews 93 (1), 137-188, 2013
16122013
Oxidative stress as a major culprit in kidney disease in diabetes
JM Forbes, MT Coughlan, ME Cooper
Diabetes 57 (6), 1446-1454, 2008
11502008
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes
R Candido, JM Forbes, MC Thomas, V Thallas, RG Dean, WC Burns, ...
Circulation research 92 (7), 785-792, 2003
5592003
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)
MD Oldfield, LA Bach, JM Forbes, D Nikolic-Paterson, A McRobert, ...
The Journal of clinical investigation 108 (12), 1853-1863, 2001
5152001
Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy
C Tikellis, CI Johnston, JM Forbes, WC Burns, LM Burrell, J Risvanis, ...
Hypertension 41 (3), 392-397, 2003
4092003
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes
A Soro-Paavonen, AMD Watson, J Li, K Paavonen, A Koitka, AC Calkin, ...
Diabetes 57 (9), 2461-2469, 2008
4062008
AGE, RAGE, and ROS in diabetic nephropathy
ALY Tan, JM Forbes, ME Cooper
Seminars in nephrology 27 (2), 130-143, 2007
3762007
Methylglyoxal modification of Na v 1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy
A Bierhaus, T Fleming, S Stoyanov, A Leffler, A Babes, C Neacsu, ...
Nature medicine 18 (6), 926-933, 2012
3672012
RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes
MT Coughlan, DR Thorburn, SA Penfold, A Laskowski, BE Harcourt, ...
Journal of the American Society of Nephrology 20 (4), 742-752, 2009
3672009
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis
JM Forbes, LTL Yee, V Thallas, M Lassila, R Candido, ...
Diabetes 53 (7), 1813-1823, 2004
3632004
Role of advanced glycation end products in diabetic nephropathy
JM Forbes, ME Cooper, MD Oldfield, MC Thomas
Journal of the American Society of Nephrology 14 (suppl 3), S254-S258, 2003
3622003
Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy
JM Forbes, ME Cooper, V Thallas, WC Burns, MC Thomas, GC Brammar, ...
Diabetes 51 (11), 3274-3282, 2002
3512002
Brain atrophy in type 2 diabetes: regional distribution and influence on cognition
C Moran, TG Phan, J Chen, L Blizzard, R Beare, A Venn, G Münch, ...
Diabetes care 36 (12), 4036-4042, 2013
3462013
High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus
BG Drew, SJ Duffy, MF Formosa, AK Natoli, DC Henstridge, SA Penfold, ...
Circulation 119 (15), 2103, 2009
3452009
Inhibition of NADPH oxidase prevents advanced glycation end product–mediated damage in diabetic nephropathy through a protein kinase C-α–dependent pathway
V Thallas-Bonke, SR Thorpe, MT Coughlan, K Fukami, FYT Yap, ...
Diabetes 57 (2), 460-469, 2008
3222008
The breakdown of pre‐existing advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes
JM Forbes, V Thallas, MC Thomas, HW Founds, WC Burns, G Jerums, ...
The FASEB Journal 17 (12), 1762-1764, 2003
3072003
Connective tissue growth factor plays an important role in advanced glycation end product–induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal …
WC Burns, SM Twigg, JM Forbes, J Pete, C Tikellis, V Thallas-Bonke, ...
Journal of the American Society of Nephrology 17 (9), 2484-2494, 2006
3032006
Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy
JM Forbes, SR Thorpe, V Thallas-Bonke, J Pete, MC Thomas, ER Deemer, ...
Journal of the American Society of Nephrology 16 (8), 2363-2372, 2005
2572005
Diabetic nephropathy: where hemodynamics meets metabolism
JM Forbes, K Fukami, ME Cooper
Experimental and clinical endocrinology & diabetes 115 (02), 69-84, 2007
2152007
Effects of SGLT2 inhibition in human kidney proximal tubular cells—renoprotection in diabetic nephropathy?
U Panchapakesan, K Pegg, S Gross, MG Komala, H Mudaliar, J Forbes, ...
PloS one 8 (2), e54442, 2013
2062013
The system can't perform the operation now. Try again later.
Articles 1–20